Clinical Trials Logo

Pertrochanteric Fracture clinical trials

View clinical trials related to Pertrochanteric Fracture.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05398757 Recruiting - Clinical trials for Postoperative Cognitive Dysfunction

Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD

ProDex-POCD
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This study will examine the effect of intraoperative sedation with midazolam, propofol and dexemdetomidine on the occurrence of postoperative cognitive impairment in patients undergoing surgical treatment of pertrochanteric fracture of the femur.

NCT ID: NCT05079087 Recruiting - Pain, Postoperative Clinical Trials

Pericapsular Nerve Group Block for Positional Pain and Postoperative Analgesia in Hip Fractures

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The aims of this study are: - Evaluate the effectiveness of the pericapsulare blockade of the femoral nerve, the accessory obturator nerve and the obturator nerve in patients with pertrochanteric fractures of the femur, during the pre-operative period for patient positioning manoeuvres (sitting position for performing spinal anaesthesia, mobilisation on the operating bed, etc.); - Evaluate the consumption of opioids or hypnotics in the perioperative period, which are more responsible for the incidence of delirium in the elderly patient; - Evaluate the duration and quality of postoperative analgesia and well-being.

NCT ID: NCT04851509 Recruiting - Clinical trials for Pertrochanteric Fracture

Static Helical Screw Locking of Pertrochanteric Femur Fractures Using the TFN-A

TFN-A
Start date: May 17, 2021
Phase: N/A
Study type: Interventional

The study will investigate the shortening and collapse of pertrochanteric fractures following surgical management with the TFN-Advanced nailing system. The focus will be on comparing radiographic assessments of nails which have been statically locked versus dynamically locked. This is a randomized control study with the initial invention being randomized to either statically locking or dynamically locking. For a two-month period, all eligible patients will receive the randomized allocated treatment, then treatment will switch to the alternate treatment for the next two months and will continue to alternate treatments for two-month periods until study enrollment has completed.